Predictive role of the monocyte-to-lymphocyte ratio in advanced hepatocellular carcinoma patients receiving anti-PD-1 therapy

BACKGROUND: The immune checkpoint inhibitor (ICIs) therapy has been proven effective in a range of solid tumors including hepatocellular carcinoma (HCC), non-small cell lung carcinoma and metastatic melanoma. However, only a subset of approximately 20% of patients shows an objective response to anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhen-Feng, Zhuang, Li-Ping, Zhang, Chen-Yue, Ning, Zhou-Yu, Wang, Dan, Sheng, Jie, Hua, Yong-Qiang, Xie, Jing, Xu, Li-Tao, Meng, Zhi-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841669/
https://www.ncbi.nlm.nih.gov/pubmed/35261893
http://dx.doi.org/10.21037/tcr-21-1760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841669/
https://www.ncbi.nlm.nih.gov/pubmed/35261893
http://dx.doi.org/10.21037/tcr-21-1760

Ejemplares similares